HENWOOD GERALDINE (President and CEO) reported 1 transaction at BAUDAX BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/14/2021ACC: 0000899243-21-048181
DirectorOfficer· President and CEO
Since Nov 2019
-9.15K
Net shares
Net seller
$3.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.15K
Price / share
$0.35
Trade value
$3.20K
% of position
2.5%
12/5/2021
364.51K→355.35K
Total
Net shares
−9.15K
Net value
-$3.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2021 | F · Tax Withholding | −9.15K | $0.35 | $3.20K | 2.5% | 364.51K | 355.35K |
| Total | −9.15K | -$3.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported